134 search results for: burden of disease

Master Clinician Video | Empowering Our Patients: Patient-Centered Practice and Follow-Up in the Clinic (Chapter 4)
Gastroenterology
Master Clinician Video | Empowering Our Patients: Patient-Centered Practice and Follow-Up in the Clinic (Chapter 4)
videoanimation

This chapter focuses on the importance of shared decision-making and regular, long-term monitoring of histology and endoscopy, not just symptoms.

View more
ADVENT at ERS-ISIAN 2025
Congress
20
June
2025
Congress
ADVENT at ERS-ISIAN 2025

Join experts Vibeke Backer, MD, DMSC, and Sietze Reitsma, MD, at an educational symposium involving a comprehensive exploration of the type 2 inflammation and its pivotal role in the pathogenesis and management of CRSwNP.

EoE Pocket Guide
Gastroenterology
EoE Pocket Guide
interactivity

The digital EoE Pocket Guide is an at-your-fingertips resource on symptoms and adaptive behaviors, EREFS scoring, and histologic features in EoE.

View more
Master Clinician Video | A Closer Look: EoE Histologic Features Under the Microscope (Chapter 3)
Gastroenterology
Master Clinician Video | A Closer Look: EoE Histologic Features Under the Microscope (Chapter 3)
videoanimation

This chapter highlights other histologic features beyond eosinophil count that may be present in patients with EoE.

View more
Assessing EoE: Monitoring Patients With EoE in Clinical Practice
Gastroenterology
Assessing EoE: Monitoring Patients With EoE in Clinical Practice
expert video

Hear Dr. Ulrike von Arnim discuss the expert recommendations for monitoring patients with EoE in routine clinical practice.

View more
Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
Type 2 Inflammation Contributes to Itch and Fibrois in PN
expert video

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

View more
Food Bolus Impaction: An Opportunity to Diagnose EoE
Gastroenterology
Food Bolus Impaction: An Opportunity to Diagnose EoE
expert video

Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.

View more
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
Pulmonology
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?
expert video

Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.

View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

ESPGHAN 2026
On Demand
Pediatric EoE: An Interactive Learning Symposium

Join leading experts in pediatric eosinophilic esophagitis (EoE), Professors Salvatore Oliva, MD, PhD, and André Hörning, MD, as they explore the multifaceted journey of pediatric patients with EoE through a hypothetical patient case, navigating real-world challenges in managing EoE.

Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment
Dermatology
Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller discusses how moderate-to-severe AD may hinder growth in pediatric patients and highlights data showing treatment with dupilumab may increase vertical growth in children of lower stature.

View more
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more